Freestone Grove Partners »

Royalty Pharma shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $30M 616k 47.97

More positions owned by Freestone Grove Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Johnson & Johnson (JNJ)
Citigroup Com New (C)
Axis Cap Hldgs SHS (AXS)
Datadog Cl A Com (DDOG)
Booz Allen Hamilton Hldg Cor Cl A (BAH)
BP Sponsored Adr (BP)
Elastic N V Ord Shs (ESTC)
Pinnacle Finl Partners (PNFP)
Intuitive Surgical Com New (ISRG)
Dynatrace Com New (DT)
Xcel Energy (XEL)
Mondelez Intl Cl A (MDLZ)

View all positions for Freestone Grove Partners

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
FMR
BlackRock
Baillie Gifford & Co
Adage Capital Partners GP
Swedbank AB
State Street Corporation
Vanguard Group
Capital World Investors
Geode Capital Management
Caledonia
Victory Capital Management
Vanguard Capital Management
Northern Trust

View all funds holding Royalty Pharma